Pilot Study of a Behavioral Program for Resident Depression in Skilled Nursing Facilities

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Massachusetts General Hospital
Study ID
NCT07655232
Status
Recruiting

Conditions

  • Depression
  • Feasibility Studies
  • Nursing Home Resident
  • Skilled Nursing Facility

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Interventions for Stressful Transitions in Later Life (InSTILL) for Individuals — BEHAVIORAL
    The Interventions for Stressful Transitions in Later Life (InSTILL) intervention is for skilled nursing facility residents experiencing elevated levels of psychological distress. The intervention is designed to improve life management skills and emotion regulation skill with the goal of reducing depression symptoms.

Study Details

The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL, for Individuals) for skilled nursing facility residents. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. Participants will join 6 bi-weekly sessions of the InSTILL program. Participants will complete assessments at three timepoints (all) and a brief-exit interview.

Key Dates

Start date
Nov 17, 2025
Status verified
Jun 2026
Primary completion
Oct 1, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: InSTILL for Individuals
    Participants in this arm will participate in the Interventions for Stressful Transitions in Later Life (InSTILL), a behavioral health intervention tailored to the needs of short stay nursing facility residents. InSTILL for Individuals includes 6 sessions (2x per week for about 3 weeks) delivered in person or remotely.

Primary Outcome Measure

Mean Total Score Treatment Credibility [ Time Frame: After session 1 of intervention, an average of 1 week after baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Massachusetts General HospitalBostonMassachusetts02114
BRISK Study Coordinator
617-643-9406

Find similar trials in Boston, MA

By condition

Related Studies